Bone marrow mesenchymal stem cells, collagen scaffold and BMP-2 for rat spinal fusio

The use of autograft for posterolateral spinal fusion, continue being considered the gold standard for the treatment of spine pathologies. However, due to complications such as donor site morbidity, increased operating time, and limited supply, the use of allograft has become an acceptable practice especially in multisegment arthrodesis or in patients with previous graft harvests. Since their use involves the risk of immune response or disease transmission and fusion rates are not as good as with autogenous bone, a variety of bone graft substitutes are being studied to obtain a better alternative. Osteoinductive growth factors, which initiate the molecular cascade of bone formation and play a key role in the development and regeneration of the skeletal system, have been shown to be effective in numerous animal studies. These molecules must be used in combination with a biomaterial to avoid their dispersion from the application site. On the other hand, it is well known that cultured bone marrow cells, harvested from adult bone marrow, may contribute to the regeneration of bone. Thus, hybrid constructs can be used as alternatives to autologous and allogenic grafts. In this study, we have evaluated different combination of cultured bone marrow cells with recombinant human osteoinductive growth factors, all of them in combination with a natural polimeric carrier, for the promotion of posterolateral spinal fusion in rats. Supported by grants from the Red de Terapia Celular (RD12/0019/0032), Spanish Government BIO2012-34960, and the Andalusian Government (P11-CVI 07245).Universidad de Málaga. Campus de Excelencia Internacional Andalucía Tech

Binomio naturaleza-salud urbana; pasado, presente y futuro

Producción CientíficaEl artículo presenta una reflexión sobre el papel que ha jugado y juega la naturaleza en las ciudades en la promoción de la salud humana. Para ello, hace una breve revisión histórica, que parte del periodo de la Ilustración y llega hasta nuestros días, en los que la vegetación en las ciudades está recobrando un protagonismo que perdió en la segunda mitad del siglo XX. Los beneficios (directos e indirectos) que la vegetación y los espacios naturalizados aportan a la salud en los ámbitos urbanos son múltiples y cada vez más estudiados. En el artículo también se hace una revisión de algunos de ellos, con el objetivo de su necesaria divulgación, que contribuya a la concienciación de diferentes agentes: desde la ciudadanía en general hasta los poderes políticos. Esto es particularmente importante en el momento actual, en el que cada vez más trabajos científicos vinculan la pérdida de biodiversidad con las enfermedades de origen zoonótico, y en el que se admite, de manera inequívoca, que la mala calidad del aire en las ciudades causa muertes y problemas de salud de diversa índole.PIP FUNGEUVa_063/212431_Naturaleza y ciudad. Investigación sobre la evolución de la relación naturaleza-ciudad en Valladolid capy AIRUSE (LIFE11 ENV/ES/000584) Testing and Development of air quality mitigation measures in Southern Europe

The use of envi-met for the assessment of nature-based solutions’ potential benefits in industrial parks—a case study of Argales Industrial Park (Valladolid, Spain)

Urbanization causes major changes in environmental systems, including those related with radiation balances and other meteorological conditions because of changes in surfaces and the physical environment. In addition, cities generate specific microclimates as a consequence of the diverse conditions within the urban fabric. Industrial parks represent vast urban areas, often neglected, contributing to the degradation of the urban environment, including poor thermal comfort as a result of soil sealing and low albedo surfaces. Nature-Based Solutions (NBS) can promote the mitigation of the anthropic effects of urbanization using nature as an inspiration. The present study, aimed at estimating the microclimate conditions in a fraction of the Argales industrial park in the city of Valladolid (Spain), with the use of the ENVI-Met software, assesses the current situation and a planned NBS scenario. Base scenario simulation results demonstrate different conditions across the simulations, with higher temperatures on sun-exposed surfaces with low albedo, and lower temperature spots, mostly associated with shadowed areas near existent buildings. After the simulation of the NBS scenario, the results show that, when compared with the base scenario, the projected air temperature changes reach reductions of up to 4.30 ◦C for the locations where changes are projected from impervious low albedo surfaces to shaded areas in the vicinity of trees and a water body.The authors are grateful to the Foundation for Science and Technology (FCT, Infrastructures 2022, 7, x FOR PEER REVIEW 20 of 23 Portugal) for financial support by national funds FCT/MCTES to CIMO (UIDB/00690/2020). Appreciation must also go to the other INTERREG POCTEP INDNATUR Project partners for the help and support during this study with the provision of means that helped a lot in the research. To the Polytechnic Institute of Bragança and the University of Valladolid that supported the collaboration in Polytechnic Institute of Bragança and the University of Valladolid that supported the collaboration tihnetphreopjercotj.ect

Aplicación de Soluciones basadas en la Naturaleza en áreas industriales para su contribución a la adaptación y mitigación del cambio climático.

La comunicación que se presenta quiere dar cuenta de los resultados parciales de investigación logrados hasta la fecha por el proyecto Interreg Poctep denominado INDNATUR_Mejora del entorno urbano en áreas industriales, adaptación al cambio climático y mejora de la calidad del aire a través de la aplicación de Soluciones basadas en la Naturaleza (SbN). Concretamente, dicha comunicación se centra en el análisis de aquel tipo de SbN que puedan aplicarse con mayor probabilidad de éxito en áreas industriales consolidadas, ya que estos ámbitos tienen unas peculiaridades y unas dificultades, inherentes a sus funciones, que hacen compleja la inclusión de dichas SbN. Dado que el proyecto INDNATUR tiene como actividad principal la realización de sendos corredores verde-azul que concentren SbN en los polígonos industriales de Argales (Valladolid) y Cantarias (Bragança), de forma previa a la toma de decisiones sobre las soluciones más adecuadas, se ha realizado un análisis sobre el estado de la cuestión en relación a SbN en áreas industriales para, posteriormente, elaborar un “catálogo de fichas de Soluciones basadas en la Naturaleza para su aplicación en polígonos industriales”, que es, hasta la fecha, el principal resultado obtenido, dado que aún no han comenzado a ejecutarse las obras.Programa: Interreg V-A España-Portugal POCTEP 2014-2020, Unión Europea (Fondos FEDER). Código del proyecto: 0599_INDNATUR_2_E, 2019-202

Species-Specific Expansion and Molecular Evolution of the 3-hydroxy-3-methylglutaryl Coenzyme A Reductase (HMGR) Gene Family in Plants

Kazakh dandelion (Taraxacum kok-saghyz, Tk) is a rubber-producing plant currently being investigated as a source of natural rubber for industrial applications. Like many other isoprenoids, rubber is a downstream product of the mevalonate pathway. The 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) enzyme catalyzes the conversion of 3-hydroxy-3-methylglutaryl-CoA to mevalonic acid, a key regulatory step in the MVA pathway. Such regulated steps provide targets for increases in isoprenoid and rubber contents via genetic engineering to increase enzyme activities. In this study, we identify a TkHMGR1 gene that is highly expressed in the roots of Kazakh dandelion, the main tissue where rubber is synthesized and stored. This finding paves the way for further molecular and genetic studies of the TkHMGR1 gene, and its role in rubber biosynthesis in Tk and other rubber-producing plants

Unequal allelic expression of wild-type and mutated β-myosin in familial hypertrophic cardiomyopathy

Familial hypertrophic cardiomyopathy (FHC) is an autosomal dominant disease, which in about 30% of the patients is caused by missense mutations in one allele of the β-myosin heavy chain (β-MHC) gene (MYH7). To address potential molecular mechanisms underlying the family-specific prognosis, we determined the relative expression of mutant versus wild-type MYH7-mRNA. We found a hitherto unknown mutation-dependent unequal expression of mutant to wild-type MYH7-mRNA, which is paralleled by similar unequal expression of β-MHC at the protein level. Relative abundance of mutated versus wild-type MYH7-mRNA was determined by a specific restriction digest approach and by real-time PCR (RT-qPCR). Fourteen samples from M. soleus and myocardium of 12 genotyped and clinically well-characterized FHC patients were analyzed. The fraction of mutated MYH7-mRNA in five patients with mutation R723G averaged to 66 and 68% of total MYH7-mRNA in soleus and myocardium, respectively. For mutations I736T, R719W and V606M, fractions of mutated MYH7-mRNA in M. soleus were 39, 57 and 29%, respectively. For all mutations, unequal abundance was similar at the protein level. Importantly, fractions of mutated transcripts were comparable among siblings, in younger relatives and unrelated carriers of the same mutation. Hence, the extent of unequal expression of mutated versus wild-type transcript and protein is characteristic for each mutation, implying cis-acting regulatory mechanisms. Bioinformatics suggest mRNA stability or splicing effectors to be affected by certain mutations. Intriguingly, we observed a correlation between disease expression and fraction of mutated mRNA and protein. This strongly suggests that mutation-specific allelic imbalance represents a new pathogenic factor for FHC

Reconfiguring ruins: Beyond Ruinenlust

What explains the global proliferation of interest in ruins? Can ruins be understood beyond their common framing as products of European Romanticism? Might a transdisciplinary approach allow us to see ruins differently? These questions underpinned the Arts and Humanities Research Council–funded project Reconfiguring Ruins, which deployed approaches from history, literature, East Asian studies, and geography to reflect on how ruins from different historical contexts are understood by reference to different theoretical frameworks. In recognition of the value of learning from other models of knowledge production, the project also involved a successful collaboration with the Museum of London Archaeology and the artist-led community The NewBridge Project in Newcastle. By bringing these varied sets of knowledges to bear on the project’s excavations of specific sites in the United Kingdom, the United States, and Japan, the article argues for an understanding of ruins as thresholds, with ruin sites providing unique insights into the relationship between lived pasts, presents, and futures. It does so by developing three key themes that reflect on the process of working collaboratively across the arts, humanities, and social sciences, including professional archaeology: inter- and transdisciplinarity, the limits of cocreation, and traveling meanings and praxis. Meanings of specific ruins are constructed out of specific languages and cultural resonances and read though different disciplines, but can also be reconfigured through concepts and practices that travel beyond disciplinary, cultural, and linguistic borders. As we show here, the ruin is, and should be, a relational concept that moves beyond the romantic notion of Ruinenlust

Mortality and pulmonary complications in patients undergoing surgery with perioperative sars-cov-2 infection: An international cohort study

Background The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. Findings This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (740%) had emergency surgery and 280 (248%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (261%) patients. 30-day mortality was 238% (268 of 1128). Pulmonary complications occurred in 577 (512%) of 1128 patients; 30-day mortality in these patients was 380% (219 of 577), accounting for 817% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 175 [95% CI 128-240], p<00001), age 70 years or older versus younger than 70 years (230 [165-322], p<00001), American Society of Anesthesiologists grades 3-5 versus grades 1-2 (235 [157-353], p<00001), malignant versus benign or obstetric diagnosis (155 [101-239], p=0046), emergency versus elective surgery (167 [106-263], p=0026), and major versus minor surgery (152 [101-231], p=0047). Interpretation Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. Funding National Institute for Health Research (NIHR), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.

PURPOSE: As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19-free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS: This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19-free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS: Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19-free surgical pathways. Patients who underwent surgery within COVID-19-free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19-free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19-free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION: Within available resources, dedicated COVID-19-free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study

PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19–free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19–free surgical pathways. Patients who underwent surgery within COVID-19–free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19–free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score–matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19–free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION Within available resources, dedicated COVID-19–free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks